Details

NameSymbolSector
LUPIN LTDLUPINPharmaceuticals
Open
2360
High
2362.8
Low
2235
Close
2300
Volume
3762236
Exchange
nse
Time
10-Aug-2026

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Lupin is  
Long Body
Estimated Stoploss of Lupin is ₹  
2362.8
Lupin has a  
Bearishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Lupin maybe  
Unpredictableℹ
, but keep a lookout for fall in price. 

Trend

Lupin is in  
Sideways trendℹ
. 
Price of Lupin is  
Downℹ
 by  

3.81

%. 
Target
Buy @ 

2177.92

Sell @ 

2537.06

Current @ 

2300

Volume

The trades of Lupin have been in  
Immenseℹ
 volume. 
The volume trades for Lupin are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Lupin is  

Up

 by  

236.27

% 

Valuation

The current market price of Lupin is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 29204cr and total assets worth ₹ 29204cr, the balance sheet of Lupin is:  
Balancedℹ
. 
Cashflow
Lupin has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 559cr

. It is  
Upℹ
 by  

325.4

%. 

(*Mar 2025)

33.69% i.e. ₹ 2999cr earned in operatingℹ
46.86% i.e. ₹ 4171cr spent in investingℹ
19.45% i.e. ₹ 1731cr earned in financingℹ
0% in otherℹ
Lupin has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 248cr

. It is  
Downℹ
 by  

190.84

%. 

(*Mar 2024)

48.36% i.e. ₹ 3648cr earned in operatingℹ
22.69% i.e. ₹ 1712cr spent in investingℹ
28.95% i.e. ₹ 2184cr spent in financingℹ
0% in otherℹ
Income
The income of Lupin is  

₹ 7137cr

 and  

Profit

 is :  

₹ 1484cr

(*Sep 2025)

Lupin Profit is up by:  

21.54

% and Income is Up by:  

12.45

% 

(*Sep 2025)

The income of Lupin is  

₹ 6347cr

 and  

Profit

 is :  

₹ 1221cr

(*Jun 2025)

Lupin Profit is up by:  

56.14

% and Income is Up by:  

10.88

% 

(*Jun 2025)

The income of Lupin is  

₹ 5724cr

 and  

Profit

 is :  

₹ 782cr

(*Mar 2025)

Lupin Profit is down by:  

8.86

% and Income is Down by:  

1.67

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.